Immunological modifications following chemotherapy are associated with delayed recurrence of ovarian cancer
This study was conducted to determine why some high grade serous ovarian cancer (HGSOC) patients recur earlier than others following treatment Overall design: Tumor samples were obtained from twenty-four patients diagnosed with FIGO Stage III / IV HGSOC before and after they were treated with 6 cycles of Carboplatin and Paclitaxel